Logo

Take That

Jul 20, 2009

After worries that their data for their experimental lupus drug wouldn't be up to snuff, Human Genome Sciences is vindicated. According to Bloomberg, Benlysta met the goals of its clinical study, finding that it "was more effective at easing pain, hair loss and skin rash than a placebo." This report sent the company's stock upwards by 200 percent from to $10.01, reports MarketWatch this morning.

Breaking News
The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.